AsianScientist (July 5, 2017) – iCarbonX, a Chinese health data company, has joined a Series B round investment in HealthLoop, a company located in Mountain View, California. The integration of HealthLoop’s patients-generated data is expected to advance iCarbonX’s data mining technology and help to establish its visionary digital life ecosystem.
Other investors of HealthLoop include NextEquity, Lafayette General Hospital through its Health Innovation Fund, Canvas Ventures and Summation Health Ventures. From all these investors, HealthLoop has raised US$8.4 million in all, which will be used in expanding its market and boosting its business teams.
“The investment in HealthLoop is in line with our strategic planning. The big data era of life sciences has just been launched, whereas a lot of previously dismissed healthcare data has just begun to show its significance. The HealthLoop platform has done an excellent job in connecting patients and doctors, tracking patients’ recovery process and mining patients’ data. All of these are essential components of iCarbonX’s digital life ecosystem,” said Dr. Wang Jun, founder of iCarbonX.
HealthLoop, a world-leading platform for automated doctor-patient interaction, was established by Dr. John Shlain in 2009. It helps to digitally connect patients with their doctors and care-givers. This enables automated patient care coordination by providing its users with clinical information and post-hospitalization follow-up care plans.
HealthLoop’s platform is designed to keep track of patients’ illness. It uses an analytics engine to provide real-time analysis of all sets of patients-generated data, thus allowing the medical and nursing team to commit their time to those patients and medical issues most in need.
In this way, the platform pushes the doctor-patient relation beyond the clinic, and facilitates boundary crossing between different groups. It not only saves doctors’ time but also improves diagnostic outcomes.
“When patients return from hospitals to the real world, they will be confronted with a whole series of problems that influence their post-hospital recovery in ways that are difficult to predict,” explained Shlain.
“But if we build a relationship with them, we can be there throughout the process to support them. And the further we can take that, the better it will be for patients’ lives and the better the outcome will be. The important thing is that the technology exists. What we’re looking for is the imagination and the right healthcare players to recognize that opportunity and embrace it.”
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.